Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
MindBio Therapeutics Corp.
C.MBIO
Healthcare
Biotechnology
MindBio Therapeutics Corp is a pioneering clinical stage biotechnology company that specializes in developing psychedelic microdosing treatments for mental health conditions. MindBio has obtained government and regulatory approvals for at-home LSD microdosing in clinical trials, making it the only organization in the world to do so.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:MBIO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
Next
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on May 30, 2024 5:01am
Buzz on the Bullboards: Volatility persists in the face of economic indicators
Canada’s main stock index struggled and the NASDAQ hit a high, demonstrating a continued appetite for tech stocks amidst market volatility.
read article.
(472)
•••
Smokey1958
X
View Profile
View Bullboard History
Comment by
Smokey1958
on May 26, 2024 5:12pm
RE:Enveric
Subsequent to this Enveric received the following notification: https://www.sec.gov/ix?doc=/Archives/edgar/data/890821/000149315224021096/form8-k.htm
A Strategic Focus on Technology-Driven AI-Powered Healthcare Solutions
posted Jun 03, 2024 9:00am by
Safe Supply Streaming Co Ltd.
-
|
The AI-powered healthcare market is set to revolutionize the industry, with the market size expected to grow from $6.9 billion in 2021 to $67.4 billion by 2027, at a CAGR of 44.9%. Technology driven solutions around mental health, counselling, addiction, and harm reduction testing provide the most attractive and strategic opportunities ...read more
(472)
•••
Smokey1958
X
View Profile
View Bullboard History
Post by
Smokey1958
on May 26, 2024 5:08pm
Enveric
Here is the first document, Form 8-K, that Enveric had to submit to avoid immediate de-listing. They have complied, to no surprise, and will this have time to move forward ...positively. https://www
...more
(472)
•••
Smokey1958
X
View Profile
View Bullboard History
Comment by
Smokey1958
on May 26, 2024 11:15am
RE:RE:RE:Enveric doesn’t meet Nasdaq listing requirements
Here is the website on the process for delisting. https://waterfrontonline.blog/wp-content/uploads/2022/10/delistingrules.pdf
(472)
•••
Smokey1958
X
View Profile
View Bullboard History
Comment by
Smokey1958
on May 26, 2024 11:14am
RE:RE:Enveric doesn’t meet Nasdaq listing requirements
Make sure you don't cherry pick only that which supports your point of view??? The following is part of the overview of delisting as explained within the website below: Return to Compliance
...more
(1713)
•••
MrForthright
X
View Profile
View Bullboard History
Comment by
MrForthright
on May 25, 2024 2:37pm
RE:Enveric doesn’t meet Nasdaq listing requirements
Plus they have NO cash and a HUGE debt. complete bust
(2)
•••
RennebergsRash
X
View Profile
View Bullboard History
Post by
RennebergsRash
on May 24, 2024 7:59pm
Enveric doesn’t meet Nasdaq listing requirements
Weird how supposedly Enveric is MBIOs path to the nasdaq but it's sp seems to indicate it will probably be pulled from the nasdaq unless it consolidates.
(472)
•••
Smokey1958
X
View Profile
View Bullboard History
Comment by
Smokey1958
on May 20, 2024 5:58pm
RE:RE:RE:Beware the Aussie Bullies
You might want to (a) read the whole report on sedar (b) consider the conversion of a major loan to shares (as requested by the lender) (c) understand it's an early stage pharma company
...more
(1713)
•••
MrForthright
X
View Profile
View Bullboard History
Comment by
MrForthright
on May 20, 2024 3:40pm
RE:RE:Beware the Aussie Bullies
Broke = see www.sedarplus.com, all there
(472)
•••
Smokey1958
X
View Profile
View Bullboard History
Comment by
Smokey1958
on May 20, 2024 12:46pm
RE:Beware the Aussie Bullies
How is MBIO broke? How many aliases do you have? Where is the evidence? MBIO has the following going for it so it ain't broke, genius: * it's a startup ....so of course it has more
...more
(1713)
•••
MrForthright
X
View Profile
View Bullboard History
Post by
MrForthright
on May 18, 2024 5:10pm
Beware the Aussie Bullies
They are promoting broke companies like $MBIO and $SPAI. Stay away
(2)
•••
Sleepydog24
X
View Profile
View Bullboard History
Post by
Sleepydog24
on May 14, 2024 10:55pm
The writing is on the wall
What today's news release left out is the game plan of Mindbio becoming Nazdaq listed through this deal with Enveric ... Mindbio needed a clean structured Psych company already listed and they
...more
(472)
•••
Smokey1958
X
View Profile
View Bullboard History
Comment by
Smokey1958
on May 14, 2024 11:34am
RE:Why Would Enveric Do This?
This may be the "link" to MBIO I suggested in the first post. According to the Enveric website their next step for this particular formulation was in looking to do an FIH (first in human
...more
(472)
•••
Smokey1958
X
View Profile
View Bullboard History
Post by
Smokey1958
on May 14, 2024 10:03am
Why Would Enveric Do This?
The potential in this is extraordinary for both companies. I would expect that the reasons for Enteric entering into an agreement like this is that they have a much faster path to clinical trials for
...more
(8)
•••
RocketRed777
X
View Profile
View Bullboard History
Post by
RocketRed777
on May 14, 2024 9:53am
ENVERIC BIOSCIENCES SIGNS $66.5 MILLION
Mindbio signs term sheet for Enveric psilocin prodrugs 2024-05-14 09:35 ET - News Release Shares issued 135,047,305 MBIO Close 2024-05-13 C$ 0.055 Mr. Justin Hanka reports
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 14, 2024 8:11am
New Press Release - Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders
MindBio to develop the novel psilocin prodrug for neuropsychiatric indications utilizing microdosing to reduce or eliminate hallucinogenic impact of psychedelic compounds Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of...
read article.
Prev
1
2
3
4
5
6
7
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Leading Intermediate Drilling Co. Poised to Capitalize on Market Conditions
This Small-Cap Gold Stock Jumped Almost 50% on Friday
A Junior Copper-Gold Stock Trading at a Bargain of Monumental Proportions